1. Home
  2. BOLD vs CRWS Comparison

BOLD vs CRWS Comparison

Compare BOLD & CRWS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • CRWS
  • Stock Information
  • Founded
  • BOLD 2018
  • CRWS 1957
  • Country
  • BOLD United States
  • CRWS United States
  • Employees
  • BOLD N/A
  • CRWS N/A
  • Industry
  • BOLD
  • CRWS Textiles
  • Sector
  • BOLD
  • CRWS Consumer Discretionary
  • Exchange
  • BOLD Nasdaq
  • CRWS Nasdaq
  • Market Cap
  • BOLD 33.4M
  • CRWS 30.1M
  • IPO Year
  • BOLD 2024
  • CRWS N/A
  • Fundamental
  • Price
  • BOLD $1.25
  • CRWS $2.78
  • Analyst Decision
  • BOLD Buy
  • CRWS
  • Analyst Count
  • BOLD 4
  • CRWS 0
  • Target Price
  • BOLD $4.00
  • CRWS N/A
  • AVG Volume (30 Days)
  • BOLD 143.3K
  • CRWS 28.1K
  • Earning Date
  • BOLD 11-05-2025
  • CRWS 11-12-2025
  • Dividend Yield
  • BOLD N/A
  • CRWS 11.51%
  • EPS Growth
  • BOLD N/A
  • CRWS N/A
  • EPS
  • BOLD N/A
  • CRWS N/A
  • Revenue
  • BOLD N/A
  • CRWS $86,516,000.00
  • Revenue This Year
  • BOLD N/A
  • CRWS N/A
  • Revenue Next Year
  • BOLD N/A
  • CRWS N/A
  • P/E Ratio
  • BOLD N/A
  • CRWS N/A
  • Revenue Growth
  • BOLD N/A
  • CRWS N/A
  • 52 Week Low
  • BOLD $1.00
  • CRWS $2.76
  • 52 Week High
  • BOLD $3.75
  • CRWS $4.69
  • Technical
  • Relative Strength Index (RSI)
  • BOLD 40.98
  • CRWS 35.40
  • Support Level
  • BOLD $1.37
  • CRWS $2.86
  • Resistance Level
  • BOLD $1.52
  • CRWS $2.95
  • Average True Range (ATR)
  • BOLD 0.07
  • CRWS 0.05
  • MACD
  • BOLD -0.03
  • CRWS -0.01
  • Stochastic Oscillator
  • BOLD 6.25
  • CRWS 8.58

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About CRWS Crown Crafts Inc

Crown Crafts Inc operates in the infant and toddler products segment of the consumer products industry through its wholly-owned subsidiaries. The infant and toddler products segment consists of infant and toddler bedding, bibs, soft bath products, disposable products, and accessories. The company serves a diverse range of customers including mass merchants, mid-tier retailers, juvenile specialty stores, value channel stores, grocery and drug stores, restaurants, internet accounts, wholesale clubs, and internet-based retailers. The company's brands include NoJo, Neat Solutions, Sassy, and Carousel. Its products are marketed under a variety of company-owned trademarks, under trademarks licensed from others, and as private-label goods.

Share on Social Networks: